- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04942379
Asthma Link: A Real World Application of School Supervised Asthma Therapy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The proposed 4-site pilot cluster randomized controlled trial will assess the feasibility of conducting a clinical trial of Asthma Link, a real-world school-supervised asthma therapy program. We will compare the impact of Asthma Link deployed in 2 pediatric practice sites versus Enhanced usual care deployed in 2 comparator sites, with 18 parent-child dyads enrolled per site (N=72 dyads).
Primary trial outcomes will be participant recruitment, retention, and intervention fidelity. Secondary trial outcomes will be differences in the frequency of asthma symptoms, emergency department visits, hospital admissions, courses of oral corticosteroids, spirometry values, medication adherence and school absences between intervention and enhanced usual care sites at 3, 6 and 12 month follow up. Additionally we will assess process outcomes (acceptability, adoption, costs, sustainability).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Worcester, Massachusetts, United States, 01655
- University of Massachusetts
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
STUDY INCLUSION/EXCLUSION CRITERIA:
Child Inclusion Criteria:
- Meet the eligibility criteria for Asthma Link (as described below)
- Enrolled in Asthma Link (if randomized to the Asthma Link Condition)
- Able and willing to provide informed assent
Child Exclusion Criteria:
- Unable or unwilling to provide informed assent
- Diagnosis of a serious co-morbid illness during the past 5 years
- Developmental delay that would prevent study participation.
- Planning on moving from primary residence or moving outside of the school district in the next 1 year
- A sibling to a child participating in this study
Parent Inclusion Criteria:
- Parent/guardian to patient
- 18 years or older
- Able to understand and communicate in English or Spanish
- Able and willing to provide informed consent.
Parent Exclusion Criteria:
- Adults lacking capacity
- Prisoners
Medical Provider, School Nurse, Asthma Champion Inclusion Criteria:
• Able and willing to provide informed consent
Medical Provider, School Nurse, Asthma Champion Exclusion Criteria:
• Unable or unwilling to provide informed consent
Child eligibility for children enrolled in Asthma Link:
- children aged 6-17 years (enrolled in grade 1-12)
- prescribed daily inhaled corticosteroid (ICS) for asthma
- 1 or more courses of oral steroids in the past 2 years OR 1 or more hospitalizations or ED visits for asthma in the past 2 years OR 1 or more sick visits for asthma in the past year OR Asthma Control Test (ACT) score <19
- parent/child report of poor ICS adherence on adherence checklist- i.e. child or parent says "Yes" when provider asks if they have difficulty remembering to take their medication or if they regularly take medication holidays or breaks
- able and willing to assent
- parental permission
- English or Spanish speaking
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Asthma Link
Site providers will be trained to efficiently discuss school-supervised medication administration with families and school nurses.
Providers identify children with poorly controlled asthma and poor medication adherence and offer enrollment in Asthma Link to provide school-supervised asthma therapy.
Ongoing communication occurs between the pediatric practice, school nurse and families through electronic medical record messaging and phone communication.
Data will be collected at baseline (study entry) and at 3-, 6-and 12-month follow-up.
|
Providers enroll patients in school nurse supervised daily controller asthma medication delivery
|
Active Comparator: Enhanced Usual Care
Sites will receive pediatric pulmonologist-delivered training and a workbook for pediatric practices to provide to patients on behavioral strategies to help promote asthma medication adherence.
Providers identify children with poorly controlled asthma and poor medication adherence and offer enrollment to this Enhanced Usual Care condition of study (receipt of workbook).
Data will also be collected at baseline (study entry) and at 3-, 6-and 12-month follow-up.
|
Providers counsel patients on behavioral strategies to improve medication adherence.
Patients also receive an asthma workbook outlining behavioral strategies for asthma medication adherence.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recruitment procedures assessed by number of patients screened
Time Frame: Baseline
|
Research staff will track number of patients screened during enrollment process.
|
Baseline
|
Recruitment procedures assessed by number of eligible participants
Time Frame: Baseline
|
Research staff will track number of eligible participants who meeting study criteria during the enrollment process.
|
Baseline
|
Recruitment procedures assessed by number of patients recruited into the study
Time Frame: Baseline
|
Research staff will track number of patients recruited into the study.
|
Baseline
|
Recruitment procedures assessed by number of eligible patients that refused to participate.
Time Frame: Baseline
|
Research staff will track the number of patients that refused to participate in the study along with the reasons for refusal.
|
Baseline
|
Retention of study participants (drop out)
Time Frame: Up to end of study, approximately 12 months
|
Research staff to track number of participants who drop out of the study and note reasons for not completing study.
|
Up to end of study, approximately 12 months
|
Retention of study participants (lost to follow-up)
Time Frame: Up to end of study, approximately 12 months
|
Research staff to track number of participants lost to follow-up and reasons for not completing study.
|
Up to end of study, approximately 12 months
|
Intervention Fidelity - Pediatric Practice
Time Frame: Baseline
|
Research staff to assess for intervention fidelity within the pediatric practice through a checklist for pediatric staff to assess percentage of eligible children enrolled.
|
Baseline
|
Intervention Fidelity - Percentage of enrolled students receiving intervention
Time Frame: Up to end of study, approximately 12 months
|
Research staff to assess for intervention fidelity by school nurse report of percentage of enrolled students receiving supervised therapy.
|
Up to end of study, approximately 12 months
|
Intervention Fidelity - School nurse and family participation
Time Frame: Up to end of study, approximately 12 months
|
Research staff to assess for intervention fidelity by school nurse checklist of each enrolled child attending daily school nurse sessions and his/her family bringing medication to school.
|
Up to end of study, approximately 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acceptability - Participants
Time Frame: 3 months, 6 months, 12 months
|
Research staff will assess acceptability of the study among stakeholders (parent-child dyads, medical providers, school nurses) via a survey in which we will ask stakeholders to rate each component of the Asthma Link intervention using a study specific Acceptability scale ranging from 1 (strongly disagree) to 5 (strongly agree).
Qualitative interviews will be performed with stakeholders at 12 months
|
3 months, 6 months, 12 months
|
Adoption of Asthma Link Intervention - Medical Provider
Time Frame: Baseline, 3 months, 6 months, 12 months
|
Research staff will assess adoption of the intervention via Pediatric practice log to track number of providers offering Asthma Link.
|
Baseline, 3 months, 6 months, 12 months
|
Adoption of Asthma Link Intervention - Participant
Time Frame: 3 months, 6 months, 12 months
|
Research staff will assess adoption of the intervention via survey to family at each survey timepoint of study to assess ability to obtain 2 inhalers (one for home and one for school) and deliver medicine to school.
|
3 months, 6 months, 12 months
|
Adoption of Asthma Link Intervention - School Nurse
Time Frame: Baseline, 3 months, 6 months, 12 months
|
Research staff will assess adoption of the intervention via school nurse log to track family bringing in medicine to school and frequency of child coming to nurses office to receive the medication.
|
Baseline, 3 months, 6 months, 12 months
|
Cost effectiveness of intervention
Time Frame: School nurses and pediatric practices 6 and 12 months/Parents 3, 6 and 12 months
|
Research staff will use survey questions to assess time and costs for school nurses to review the toolkit and administer the intervention, pediatric providers to implement the program, and parents to participate in the intervention
|
School nurses and pediatric practices 6 and 12 months/Parents 3, 6 and 12 months
|
Sustainability of Intervention
Time Frame: 3 months, 6 months, 12 months
|
Research staff will use a survey questions to parents, pediatric practice staff and school staff
|
3 months, 6 months, 12 months
|
Asthma Symptoms - Spirometry
Time Frame: Baseline, 3 months, 6 months, 12 months
|
Research staff will assess asthma symptoms utilizing spirometry to measure Forced Expiratory Volume.
|
Baseline, 3 months, 6 months, 12 months
|
Asthma Symptoms - Asthma Control Test
Time Frame: Baseline, 3 months, 6 months, 12 months
|
Research staff will assess asthma symptoms utilizing the validated measure: Asthma Control Test (ACT) which consists of parent's assessment of level of control over child's asthma symptoms in the previous 4 weeks.
|
Baseline, 3 months, 6 months, 12 months
|
Asthma Symptoms - Maximum Symptoms Days
Time Frame: Baseline, 3 months, 6 months, 12 months
|
Research staff will assess asthma symptoms utilizing the validated measure: Maximum Symptom Days (the largest value of the number of days in the previous 2 weeks that a parent reports that their child experienced a) cough, wheezing, or shortness of breath, b) slowed activities due to symptoms, or 3)nocturnal awakening due to these symptoms.
|
Baseline, 3 months, 6 months, 12 months
|
Frequency of healthcare utilization over time
Time Frame: Baseline, 3 months, 6 months, 12 months
|
Research staff will assess the frequency of healthcare utilization (# of emergency room visits, # of hospital admissions, # of oral steroid courses, and # of urgent care visits) due to asthma through parent report on surveys and medical record review.
|
Baseline, 3 months, 6 months, 12 months
|
Medication Adherence
Time Frame: Baseline, 3 months, 6 months, 12 months
|
Research staff will assess medication adherence via a survey questions administered to parents and through pharmacy refill data.
|
Baseline, 3 months, 6 months, 12 months
|
School absences
Time Frame: Baseline, 3 months, 6 months, 12 months
|
Research staff will assess school absences via parent report and school nurse report
|
Baseline, 3 months, 6 months, 12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Michelle Trivedi, MD, University of Massachusetts Chan Medical School
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H00016378
- 5K23HL150341 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Childhood Asthma
-
National and Kapodistrian University of AthensNot yet recruitingChildhood Asthma | Environmental Exposure | Pollution; Exposure | Childhood
-
Ohio State UniversityAmerican Nurses Foundation; Sigma Theta Tau International Honor Society of... and other collaboratorsCompletedChildhood Asthma | Childhood Anxiety Disorder | Childhood DepressionUnited States
-
University of LouisvilleMeda PharmaceuticalsCompleted
-
University of North Carolina, GreensboroSigma Theta Tau InternationalActive, not recruitingChildhood Asthma | Childhood Anxiety | Childhood DepressionUnited States
-
Khyber Teaching HospitalRecruitingChildhood Asthma With Acute ExacerbationPakistan
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Johns Hopkins All Children's HospitalCompleted
-
Montefiore Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingAsthma ChildhoodUnited States
-
Albert Einstein College of MedicineNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Children's Hospital of Fudan UniversityWithdrawnChildhood Asthma
Clinical Trials on Asthma Link
-
trueNorth Medical CentresGilead SciencesRecruiting
-
VA Ann Arbor Healthcare SystemUniversity of Michigan; Michigan Health Endowment FundRecruitingPhysical Activity | Telemedicine | Mobility | Veterans HealthUnited States
-
Liverpool University Hospitals NHS Foundation TrustCompletedAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearUnited Kingdom
-
Karen HeimerUniversity of Minnesota; U.S. Department of Justice; Cedar Rapids Community School...CompletedRisk Reduction BehaviorUnited States
-
VA Office of Research and DevelopmentCompletedHypertensionUnited States
-
Lancaster UniversityNot yet recruiting
-
Icahn School of Medicine at Mount SinaiNational Institute on Aging (NIA); Department of Health and Human Services; University...CompletedColorectal CancerUnited States
-
Imperial College Healthcare NHS TrustTerminatedHypertension, PulmonaryUnited Kingdom
-
Orthopaedische Klinik Koenig-Ludwig-HausUnknown
-
Ascensia Diabetes CareCompleted